April 29, 2022Open Access
Association of Influenza Vaccination With Cardiovascular Risk
Structured PICO
Does influenza vaccination reduce major adverse cardiovascular events in high-risk patients?
P
Population
High-risk patients, including individuals with recent acute coronary syndrome (ACS)
I
Intervention
Influenza vaccination
O
Outcome
Major adverse cardiovascular eventscomposite
Influenza vaccination is associated with a significantly lower risk of major adverse cardiovascular events, particularly in patients with recent ACS.
Abstract
In this study, receipt of influenza vaccination was associated with a 34% lower risk of major adverse cardiovascular events, and individuals with recent ACS had a 45% lower risk. Given influenza poses a threat to population health during the COVID-19 pandemic, it is integral to counsel high-risk patients on the cardiovascular benefits of influenza vaccination.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Cite this study
Behrouzi et al. (Fri,) studied this question.
synapsesocial.com/papers/69d570ca75589c71d767df37 — DOI: https://doi.org/10.1001/jamanetworkopen.2022.8873
Authors
B
Bahar Behrouzi
University of Toronto
Deepak L. Bhatt
Mount Sinai Health System
Christopher P. Cannon
Université Claude Bernard Lyon 1
Journals
JAMA Network Open
Actions
Institutions
Harvard University
University of Toronto
Brigham and Women's Hospital
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...